Provider: View Press Release
Type: Link
Title: GSK receives positive CHMP opinion recommending approval of Jemperli (dostarlimab) plus chemotherapy as a new frontline treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer | GSK
Description: Decision on EU marketing authorisation expected by the end of the year.
Provider: View Press Release
Type: Link
Title: GSK presents scientific advances to improve patient outcomes at the American Association for the Study of Liver Diseases’ The Liver Meeting® 2023 | GSK
Description: New data from the B-Together phase IIb trial contribute to the development of a functional cure for people living with CHB.
Provider: View Press Release
Type: Link
Title: GSK and ViiV Healthcare to present scientific advancements in their industry-leading infectious diseases portfolio at IDWeek 2023 | GSK
Description: First scientific presentation of RSV vaccine efficacy and safety data over two seasons.
Provider: View Press Release
Type: Link
Title: GSK and Zhifei announce exclusive strategic vaccine partnership in China | GSK
Description: Partnership will significantly extend availability of Shingrix in China with co-promotion to healthcare professionals.
Provider: View Press Release
Type: Link
Title: GSK survey finds parents know less about meningitis compared to some other childhood diseases | GSK
Description: New multi-country survey finds 93% of parents couldn’t identify all three of the most common meningitis symptoms.
Provider: View Press Release
Type: Link
Title: GSK announces Wendy Becker to join the Board as Non-Executive Director | GSK
Description: GSK has announced that Wendy Becker will join the Board of the Company as a Non-Executive Director with effect from 1 October 2023.